Healthconn Corp.

Healthconn Corp.

6665 · TWO · Healthcare / Healthcare Plans

15.60TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close15.60
Open15.60
Day Range15.00 – 15.60
52-Week Range16.40 – 24.22
Volume4.33K
Market Cap775.48M
P/E (TTM)35.63
Forward P/E0.00
EPS0.48
Dividend Yield0.86%
Beta0.43
50-Day Avg17.94
200-Day Avg19.97

About

Healthconn Corp. engages in the provision of health management and prevention solutions in Taiwan and China. The company offers personal and corporate health management, heath promotion, telehealth services, and cancer genetic testing; diagnostic devices and smart testing solutions, such as diagnostic and testing equipment, blood collection tubes and needles, laboratory information systems, automated lab integration, life science research, and cold chain logistics and medical supply delivery; genetic decoding and precision diagnostics; and clinical bacteriology testing, molecular diagnostics, serology testing, and immunology testing, as well as water quality testing. It also provides diagnostic solutions, including microbiology, total lab automation, molecular biology, life sciences, laboratory information systems, and environment and safety solutions; and warehouse and logistics services. Healthconn Corp. was founded in 2009 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Plans
  • CEOBill Tsou
  • Employees0
  • HeadquartersNo. 54, Zhongxiao East Road, Taipei, Taiwan, 100, Taiwan
  • Websitehttps://www.healthconn.com

Leadership

  • Bill TsouPresident & Director
  • Martin ChiangVice President of Operations
  • Ruojing WangAccounting Supervisor

Financials

Income Statement

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue460.45M1.11B1.73B496.71M303.29M1.36B1.55B1.26B1.25B1.13B
Growth (%)-+140.46%+56.20%-71.28%-38.94%+349.39%+13.38%-18.73%-0.20%-9.76%
Cost of Revenue181.92M586.63M1.08B220.68M159.10M1.06B1.24B1.02B1.01B927.05M
Gross Profit278.53M520.59M652.24M276.03M144.19M306.87M303.29M236.25M238.86M203.94M
Gross Margin60.49%47.02%37.71%55.57%47.54%22.51%19.63%18.81%19.06%18.03%
Operating Expense99.58M215.09M303.41M143.17M115.01M254.62M242.43M233.30M226.61M200.79M
Operating Income178.95M305.50M348.83M132.86M29.18M52.26M60.86M2.95M12.25M3.15M
Operating Margin38.86%27.59%20.17%26.75%9.62%3.83%3.94%0.23%0.98%0.28%
EBITDA209.59M352.85M408.09M174.36M60.94M127.66M123.01M66.62M90.28M70.76M
EBITDA Margin45.52%31.87%23.60%35.10%20.09%9.37%7.96%5.30%7.20%6.26%
Net Income149.96M232.85M271.02M286.22M118.03M37.43M25.44M2.36M19.23M8.39M
Net Income Margin32.57%21.03%15.67%57.62%38.92%2.75%1.65%0.19%1.53%0.74%
R&D-2.18M6.55M7.11M3.91M2.64M998.00K8.98M1.57M647.00K
R&D as % of Total Revenue-0.20%0.38%1.43%1.29%0.19%0.06%0.72%0.13%0.06%
Interest Expense43.00K183.00K931.00K5.18M4.70M5.44M6.05M6.34M5.76M5.28M
Interest Expense % of Total Revenue0.01%0.02%0.05%1.04%1.55%0.40%0.39%0.51%0.46%0.47%

Balance Sheet

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets803.28M1.23B1.40B1.43B1.40B1.77B1.66B1.54B1.52B1.49B
Total Liabilities193.83M407.59M425.65M317.35M413.31M852.30M721.97M622.49M574.28M566.77M
Total Equity609.45M822.68M975.85M1.11B990.76M922.14M942.32M916.46M947.81M926.03M
Cash551.25M510.45M552.43M251.12M254.43M839.52M767.81M649.67M366.95M296.04M
Total Debt-98.00K20.00M140.87M272.75M508.60M348.48M364.33M--
Net Debt-551.25M-510.35M-532.43M-110.25M18.32M-330.93M-419.33M-285.34M--

Cash Flow

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow189.18M291.93M251.39M214.35M124.48M85.40M166.87M62.84M17.31M66.78M
Financing Cash Flow-19.29M-33.00K-107.81M-120.11M-118.52M-71.96M-194.80M-26.38M--
Capital Expenditure43.09M32.09M34.14M12.36M2.68M74.92M70.04M14.70M20.46M23.67M
Free Cash Flow146.10M259.84M217.24M201.99M121.80M10.48M96.83M48.14M-3.15M43.10M
Dividends Paid--127.95M150.84M204.58M102.58M32.02M20.68M2.36M31.75M
FCF to OCF77.23%89.01%86.42%94.23%97.85%12.27%58.03%76.61%-18.22%64.55%
Dividend Paid to FCF--58.90%74.68%167.96%978.52%33.06%42.96%-74.75%73.67%

Key Statistics & Ratios

Market Cap775.48M
Enterprise Value841.53M
Trailing P/E35.63
Forward P/E0.00
Price / Sales0.66
Price / Book0.80
EPS0.48
Book Value20.90
Revenue (TTM)1.17B
Gross Profit (TTM)227.24M
EBITDA41.78M
Profit Margin1.83%
Operating Margin1.48%
Return on Equity2.36%
Return on Assets0.68%
Shares Outstanding45.35M
Shares Float20.52M
Beta0.43
Dividend Yield0.86%
Dividend Rate0.15
Payout Ratio146.23%

Dividends

20261×
0.15Jul 9, 2026
20251×
0.70Jul 11, 2025
20241×
0.05Jul 16, 2024
20231×
0.46Jul 19, 2023
20221×
0.71Jul 20, 2022
20211×
2.28Jul 19, 2021
20201×
4.56Jul 16, 2020
20191×
4.00Jul 30, 2019
20181×
3.17Aug 1, 2018

Stock Splits

  • Jul 30, 20191200:1000
  • Aug 1, 20181120:1000